Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Belgium / NCT02878434
Recruiting Observational

Fertility Preservation in Young Women With Cancer

NCT02878434 · tracked via the Priya Life Science Belgium tracker
Sponsor
University Hospital, Gasthuisberg
Phase
Observational
Started
2017-05-23
Last updated
2020-11-18

Condition(s) studied

CancerFertility

Study summary

The researchers aim to record the incidence, treatment and long term follow up of fertility preserving cancer treatment. Both the oncological and fertility outcome are recorded.

Study population: All patients with a cancer for whom a fertility preserving cancer treatment is applied. The results of the study population are compared to young women undergoing standard cancer treatment.

Eligibility

Sex
FEMALE
Min age
0 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria: * Young women who want to preserve their fertility during cancer treatment. Patients need to give their signed and written informed consent to participate in the study. Exclusion Criteria: * Mentally disabled or significantly altered mental status that would prohibit the understanding and giving of informed consent

Primary outcome measure(s)

  • Fertility Outcome — 10 years
    pregnancy rate

Trial sites (2)

FacilityCityRegionStatus
UZ Gasthuisberg, Katholieke Universiteit Leuven Leuven Belgium Recruiting
The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam Netherlands Recruiting

More University Hospital, Gasthuisberg trials in Belgium

Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical Assessment Recruiting
Effects of Oncological Treatment During Pregnancy on Mother and Child Recruiting
Evaluating the Impact of Cryo-analgesia on Recovery After Double Lung Transplantation Recruiting

Other trials for the same condition

The SUNRISE Project is Dedicated to Enhancing Primary Cancer Prevention Among Adolescents in Europe by Leveraging Innovative Digital Tools and Methodologies. SmartCoach, Developed by Swiss Research Institute for Public Health and Addiction (ISGF), is a Mobile Phone-based Life-skills Training Program Starting soon
Met Non Small Cell Cancer Registry (MOMENT) Recruiting
Prospective Collection of Tumor Biopsy and Plasma Samples From Cancer Patients Treated With Molecular Targeted Therapies or Immunotherapy Active, not recruiting
Fertility and Ovarian Reserve in Female Childhood Cancer Survivors Recruiting
9-ING-41 in Patients With Advanced Cancers Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02878434 on ClinicalTrials.gov ↗ ← All trials in Belgium